Finance

Lists
JNJ:NYSE
Johnson & Johnson
USD 252,93
-1,21%
(-3,10) 1D
USD 253,06
+0,05% (+0,13)
After hours
Closed: 5 Okt., 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JNJ...
Open
USD 256,00
High
USD 256,24
Low
USD 252,51
Mkt. cap
609,54 mjd
Avg. vol.
6,54 m
Volume
10,03 m
Dividend
2,12%
Quarterly dividend
USD 1,34
Ex-dividend date
25 Aug. 2026
P/E ratio
29,33
52-wk high
USD 281,07
52-wk low
USD 182,94
EPS
USD 8,62
Beta
0,21
Shares outstanding
2,41 mjd
No. of employees
138 k
Open
USD 256,00
High
USD 256,24
Low
USD 252,51
Mkt. cap
609,54 mjd
Avg. vol.
6,54 m
Volume
10,03 m
Dividend
2,12%
Quarterly dividend
USD 1,34
Ex-dividend date
25 Aug. 2026
P/E ratio
29,33
52-wk high
USD 281,07
52-wk low
USD 182,94
EPS
USD 8,62
Beta
0,21
Shares outstanding
2,41 mjd
No. of employees
138 k
News stories
From web sources and news partners
About Johnson & Johnson
CEOJoaquin Duato
Employees138 k
FoundedJan. 1886
HeadquartersNew Brunswick, New Jersey, Verenigde State van Amerika
SectorPharmaceutical industry
Websitejnj.com
Analyst ratings
Based on 18 analysts giving stock ratings to JNJ in the past 3 months
Strong buy
Buy
14
Hold
4
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for JNJ in the last 3 months.
Highest
Current USD 252,93
USD 320,00 (+26,52%)
Average
USD 288,56 (+14,09%)
Lowest
USD 260,00 (+2,80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joanne Wuensch
Citi
Buy
Maintained
USD 303,00
+19,8%
10/05/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
USD 282,00
+11,5%
10/02/2026
Chris Schott
J.P. Morgan
Hold
Maintained
USD 285,00
+12,7%
09/29/2026
Jason Gerberry
Bank of America Securities
Hold
Reiterated
USD 278,00
+9,9%
09/29/2026
Louise Chen
Scotiabank
Buy
Maintained
USD 305,00
+20,6%
09/28/2026
Michael Yee
UBS
Buy
Maintained
USD 320,00
+26,5%
09/21/2026
Trung Huynh
RBC Capital
Buy
Maintained
USD 287,00
+13,5%
09/21/2026
Michael Nedelcovych
TD Cowen
Buy
Maintained
USD 300,00
+18,6%
09/14/2026
Nico Chen
DBS
Hold
Maintained
USD 270,00
+6,7%
09/11/2026
Morten Herholdt
HSBC
Buy
Maintained
USD 320,00
+26,5%
09/10/2026
Leonid Timashev
RBC Capital
Buy
Maintained
USD 287,00
+13,5%
09/09/2026
Asad Haider
Goldman Sachs
Buy
Maintained
USD 282,00
+11,5%
08/25/2026
Vamil Divan
Guggenheim
Buy
Reiterated
USD 287,00
+13,5%
08/05/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
USD 294,00
+16,2%
08/03/2026
David Toung
Argus Research
Buy
Reiterated
USD 300,00
+18,6%
07/28/2026
David Risinger
Leerink Partners
Buy
Maintained
USD 276,00
+9,1%
07/17/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Upgraded
USD 280,00
+10,7%
07/16/2026
Jayson Bedford
Raymond James
Buy
Maintained
USD 265,00
+4,8%
07/16/2026
Rick Wise
Stifel Nicolaus
Hold
Maintained
USD 260,00
+2,8%
07/15/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
USD 287,00
+13,5%
07/13/2026
Steve Scala
TD Cowen
Buy
Maintained
USD 300,00
+18,6%
07/13/2026
Matt Miksic
Barclays
Hold
Reiterated
USD 255,00
+0,8%
05/13/2026
Hans Engel
Erste Group
Buy
Maintained
-
-
05/05/2026
Josh Jennings
TD Cowen
Buy
Maintained
USD 250,00
-1,2%
04/23/2026
Lee Hambright
Bernstein
Hold
Maintained
-
-
04/14/2026
Danielle Antalffy
UBS
Buy
Reiterated
USD 280,00
+10,7%
03/17/2026
Next call oor 7 dae
Di. 13 Okt., 14:30
Fiscal period
Q3 2026
- / USD 2,49
Revenue / Est. (USD)
- / 25,32 mjd
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
23,99 mjd
24,56 mjd
24,06 mjd
25,31 mjd
Cost of goods sold
7,29 mjd
7,81 mjd
8,09 mjd
8,02 mjd
Cost of revenue
7,29 mjd
7,81 mjd
8,09 mjd
8,02 mjd
Research and development expenses
3,67 mjd
4,25 mjd
3,53 mjd
3,65 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,78 mjd
6,61 mjd
5,85 mjd
6,25 mjd
Operating expense
9,46 mjd
10,86 mjd
9,38 mjd
9,91 mjd
Total operating expenses
16,75 mjd
18,68 mjd
17,47 mjd
17,92 mjd
Operating income
7,25 mjd
5,89 mjd
6,60 mjd
7,39 mjd
Other non operating income
17,00 m
396,00 m
-211,00 m
110,00 m
EBT including unusual items
7,49 mjd
4,97 mjd
5,99 mjd
6,75 mjd
EBT excluding unusual items
7,27 mjd
6,03 mjd
6,41 mjd
7,42 mjd
Income tax expense
2,34 mjd
-150,00 m
755,00 m
1,21 mjd
Effective tax rate
31,24%
-3,02%
12,60%
17,98%
Other operating expenses
-
-
-
-
Net income
5,15 mjd
5,12 mjd
5,24 mjd
5,53 mjd
Net profit margin
21,47%
20,83%
21,76%
21,86%
Earnings per share
2,80
2,46
2,70
2,90
Interest and investment income
227,00 m
237,00 m
229,00 m
219,00 m
Interest expense
-245,00 m
-214,00 m
-272,00 m
-281,00 m
Net interest expenses
-18,00 m
23,00 m
-43,00 m
-62,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
9,02 mjd
7,90 mjd
8,60 mjd
9,35 mjd
Gain or loss from assets sale
-57,00 m
-132,00 m
12,00 m
-55,00 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme